Eye Movement and Vision Tests in People With Multiple Sclerosis
Tests eye movement and vision speed in people with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis
Key facts
- Where
- Valladolid, SpainSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT05706220, who can take part
Where in Spain
- IOBA - Universidad de ValladolidValladolid, SpainNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
- Trial code
- NCT05706220
- Record updated
- 16 May 2025
- Original description
This project aims to analyze ocular motility problems, visual processing speed and microperimetry, and their relationship with consolidated retinal structural biomarkers (optical coherence tomography, OCT) in patients with Multiple Sclerosis w/w reading complaints comparing with healthy subjects.Read full original descriptionShow less
Visual Processing Speed and Objective Analysis of Supranuclear Ocular Movements Control in Multiple Sclerosis Patients and Its Relationship With OCT and Reading Difficulties
This project aims to analyze ocular motility problems, visual processing speed and microperimetry, and their relationship with consolidated retinal structural biomarkers (optical coherence tomography, OCT) in patients with Multiple Sclerosis w/w reading complaints comparing with healthy subjects.
Inclusion: Diagnosis of Multiple Sclerosis; Best distant corrected visual acuity equal or greater than 0.7 (decimal scale). Glasses or soft contact lenses users; Best close corrected visual acuity equal to or greater than 20/30 (Snellen scale).Glasses or soft contact lenses users.
Exclusion: Patients with a history of acute optic neuritis (ON) and/or who experienced an episode of ON <6 months prior to the study, to avoid potential interference of papilledema with accurate peripapillary RNFL thickness measurements; Patients with other retinal and optic nerve diseases, advanced cataracts according to the international Lens Opacities Classification System III (LOCS III) (opacities greater than C2N2); Patients with other ophthalmological diseases that could affect central visual acuity; Subjects with other demyelinating disorders (neuromyelitis optica or acute disseminated encephalomyelitis); Subjects with high refractive error (+ - 6 diopters).